Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ABSSSI”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Post-approval studies (Phase 4)Study completedNCT03233438
What this trial is testing

Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Who this might be right for
Bacterial InfectionsAcute Bacterial Skin and Skin Structure Infection
Allergan 91
Post-approval studies (Phase 4)Study completedNCT02925416
What this trial is testing

Safety of Either a Single or Two Intravenous Doses of Orbactiv in Participants With Acute Bacterial Skin and Skin Structure Infection

Who this might be right for
Skin Diseases, Bacterial
The Medicines Company 22
Testing effectiveness (Phase 2)Study completedNCT02052388
What this trial is testing

Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections

Who this might be right for
Skin InfectionBacterial Infection
Cellceutix Corporation 215
Testing effectiveness (Phase 2)Study completedNCT02426918
What this trial is testing

Study of Debio 1450 for Bacterial Skin Infections

Who this might be right for
Bacterial Infections
Debiopharm International SA 330
Large-scale testing (Phase 3)Study completedNCT01984684
What this trial is testing

Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Who this might be right for
Skin and Subcutaneous Tissue Bacterial InfectionsSkin Structures and Soft Tissue Infections
Melinta Therapeutics, Inc. 850
Large-scale testing (Phase 3)Study completedNCT02066402
What this trial is testing

Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Who this might be right for
Bacterial Infections
Bayer 598
Testing effectiveness (Phase 2)Study completedNCT03964493
What this trial is testing

TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection

Who this might be right for
Skin and Subcutaneous Tissue Bacterial InfectionsGram-Positive Bacterial Infections
TenNor Therapeutics Limited 120
Early research (Phase 1)Study completedNCT04919954
What this trial is testing

Tebipenem (SPR994) Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis

Who this might be right for
DiabetesWound InfectionABSSSI+1 more
Hartford Hospital 12
Testing effectiveness (Phase 2)Study completedNCT01119105
What this trial is testing

Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

Who this might be right for
Bacterial InfectionsInfection
Nabriva Therapeutics AG 210
Early research (Phase 1)Study completedNCT03873987
What this trial is testing

Relative Exposure and Safety Study of Kimyrsa in ABSSSI Patients

Who this might be right for
Acute Bacterial Skin and Skin Structure Infection
Melinta Therapeutics, Inc. 102
Large-scale testing (Phase 3)Study completedNCT01252719
What this trial is testing

Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I)

Who this might be right for
Wound InfectionAbscessSystemic Inflammation+1 more
Melinta Therapeutics, Inc. 968
Large-scale testing (Phase 3)Study completedNCT02600611
What this trial is testing

Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1

Who this might be right for
Skin Structures and Soft Tissue Infections
Motif Bio 600
Large-scale testing (Phase 3)Study completedNCT03176134
What this trial is testing

Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018)

Who this might be right for
Acute Bacterial Skin and Skin Structure Infections
Merck Sharp & Dohme LLC 100
Not applicableStudy completedNCT04959799
What this trial is testing

Dalbavancin Real-life Utilization in Diabetic Patients Suffering From Infections (DALBADIA)

Who this might be right for
DiabetesInfection
Aziende Chimiche Riunite Angelini Francesco S.p.A 98
Large-scale testing (Phase 3)Study completedNCT02607618
What this trial is testing

Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2

Who this might be right for
Skin Structures and Soft Tissue Infections
Motif Bio 613
Early research (Phase 1)Study completedNCT06394518
What this trial is testing

Phase 1, Single-Dose and Multiple-Dose Continuous Intravenous Infusions of TNP-2092 for Injection in Healthy Chinese Participants

Who this might be right for
Acute Bacterial Skin and Skin Structure Infection (ABSSSI)Prosthetic Joints Infection (PJI)
TenNor Therapeutics Inc. 32
Testing effectiveness (Phase 2)Study completedNCT02269319
What this trial is testing

MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection

Who this might be right for
Bacterial Infections
MicuRx 120
Testing effectiveness (Phase 2)Study completedNCT01211470
What this trial is testing

Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus

Who this might be right for
Acute Bacterial Skin and Skin-structure Infection(ABSSSI) Due to Staphylococcus Aureus (MSSA)(Susceptible or Methicillin Resistant)
PolyMedix, Inc. 215
Testing effectiveness (Phase 2)Study completedNCT00949130
What this trial is testing

Comparative Study of NXL103 Versus Linezolid in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Who this might be right for
Acute Bacterial Skin and Skin Structure Infections
Novexel Inc 180
Large-scale testing (Phase 3)Study completedNCT02877927
What this trial is testing

Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI

Who this might be right for
Bacterial InfectionsSkin Structures and Soft Tissue Infections
Paratek Pharmaceuticals Inc 735
Load More Results